about
Hepatitis B Virus Infection, MicroRNAs and Liver DiseaseMicroRNAs may solve the mystery of chronic hepatitis B virus infectionDeltex1 Polymorphisms Are Associated with Hepatitis B Vaccination Non-Response in Southwest ChinaNeutralization epitope responsible for the hepatitis B virus subtype-specific protection in chimpanzees.HepSEQ: International Public Health Repository for Hepatitis B.Serology based disease status of Pakistani population infected with hepatitis B virusMolecular epidemiology of Hepatitis B virus genotypes in Pakistan.Hepatitis B virus genotypes/subgenotypes in voluntary blood donors in Makassar, South Sulawesi, Indonesia.Protection against woodchuck hepatitis virus (WHV) infection by gene gun coimmunization with WHV core and interleukin-12.Low prevalence of hepatitis B virus pre-S deletion mutation in Indonesia.CD3Z genetic polymorphism in immune response to hepatitis B vaccination in two independent Chinese populationsEfficacy of Hepatitis B vaccine in those who lost Hepatitis B surface antigen during follow-up: Efficacy of HBV vaccine in those who lost HBsAgCommon genotypes of Hepatitis B virus prevalent in injecting drug abusers (addicts) of North West Frontier Province of Pakistan.The expression of miR-125b-5p is increased in the serum of patients with chronic hepatitis B infection and inhibits the detection of hepatitis B virus surface antigen.Hepatitis B virus: significance of genotypes.Molecular virology of hepatitis B virus for clinicians.The association of complex liver disorders with HBV genotypes prevalent in PakistanChronic HBV infection among pregnant women and their infants in Shenyang, ChinaDevelopment of a highly sensitive bioluminescent enzyme immunoassay for hepatitis B virus surface antigen capable of detecting divergent mutants.FAS and FASL gene polymorphisms are not associated with hepatitis B virus infection based on a case-control study in a Brazilian population.Hepatitis B virus genotypes among chronic hepatitis B patients reporting at Korle-Bu teaching hospital, Accra, Ghana.Atypical serological profiles in hepatitis B virus infection.Molecular mechanisms underlying HBsAg negativity in occult HBV infection.Changes in the prevalence of HBV infection in pregnant women in Turkey between 1995 and 2015: a 20-year evaluation.Immunization of guinea pigs with novel hepatitis B antigen as nanoparticle aggregate powders administered by the pulmonary routeRecurrence of another hepatitis B virus escape mutant comes back in a patient infected with HIV and low CD4+ count.Hepatitis B virus transmission in Brazilian hemodialysis units: serological and molecular follow-up.Molecular and serological evaluation of surface antigen negative hepatitis B virus infection in blood donors from Venezuela.Hepatitis B core antibodies in Danish blood donors: a surrogate marker of risk behaviour.The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis.Development of probiotic-based immunoparticles for pulmonary immunization against Hepatitis B
P2860
Q26801511-6E0192DC-185F-4E6E-8EE8-E7214099B796Q26827668-66551A43-382A-48B1-9C3D-210E113C2514Q28387451-E97FB3CE-D251-411E-8AED-BA3A15A800A2Q33245946-C1A5B073-97E1-491F-95E6-3575C317D2F4Q33264762-7D3F7834-5AA8-4A98-8972-79FEFE5AF682Q33289129-6A268218-5622-4B61-93A8-F070626E522AQ33301959-8EB81143-FB37-40DB-ADBD-3999A99A1B9EQ33494953-F93ADA64-16F2-4112-8C0A-50026955E63DQ33845287-C42C8096-C98E-4FD2-83E4-41103E641C54Q33991663-70E5052C-5511-48E2-BD1E-6A52C087B0F2Q34247198-376FD8F5-1D30-46DF-A5DA-149EDC62A67FQ35507472-993A9E11-4602-4A43-BF94-C439098B7EE3Q35874884-15B93344-9ACB-4B92-BA56-7BCEE47CACAAQ35939141-02987D1A-266D-45B1-BD62-6A96F9F674D1Q36048711-27FE5675-DD5F-4C24-8F8F-3A1D3FCA9148Q36282234-116E43BC-AEE9-46DD-B2A5-EFF85D19CF57Q36402124-D87D9859-069B-40D2-8CEA-6FA71EAB8AE4Q36597302-D287F48A-766D-45E1-B757-A6095CD7BCD8Q37124701-CD759D40-F6BA-4B24-9F34-D014317697A2Q37358408-91B8F6BB-8476-4DDE-8CA3-79E9233FDC5FQ37624794-693321E3-4748-484C-87E6-CB196531FB8FQ38063427-6C8E0149-5C6C-4154-90B0-981DD1791BC2Q38536404-5BED2583-0507-435A-8CFC-54EA494BF573Q39949129-BC99D5B6-9A86-48D4-A82C-DE2E3ED4D66FQ41950285-4D57CA9A-1DF1-4436-AAD5-A8D55312F2F1Q42248669-A0A0B812-300D-448D-BCCC-A3FA808FB270Q44546835-7A10674B-38A5-49C8-8DCA-03AB9080B431Q44696818-7ED55DC1-1196-49EB-A26A-33469FB144B4Q50570755-33F3B723-2972-44B8-ABCD-8E5191B117DAQ52945818-534F462E-625A-4452-9597-DE9E56880D21Q57095060-35544F45-C098-463C-9648-9E3779238EFD
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Current topics in hepatitis B.
@ast
Current topics in hepatitis B.
@en
Current topics in hepatitis B.
@nl
type
label
Current topics in hepatitis B.
@ast
Current topics in hepatitis B.
@en
Current topics in hepatitis B.
@nl
prefLabel
Current topics in hepatitis B.
@ast
Current topics in hepatitis B.
@en
Current topics in hepatitis B.
@nl
P356
P1433
P1476
Current topics in hepatitis B.
@en
P2093
Zuckerman AJ
Zuckerman JN
P304
P356
10.1053/JINF.2000.0720
P577
2000-09-01T00:00:00Z